Utah Medical Products, Inc. (UTMD)

Market Cap	238.53M +23.0%
Revenue (ttm)	36.11M -7.0%
Net Income	10.49M -16.5%
EPS	3.28 -12.4%
Shares Out	3.18M
PE Ratio	22.83
Forward PE	n/a
Dividend	$1.24 (1.66%)
Ex-Dividend Date	Sep 17, 2026

Volume	40,177
Open	74.90
Previous Close	74.79
Day's Range	74.78 - 75.33
52-Week Range	53.66 - 76.89
Beta	0.39
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 22, 2026

About UTMD

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK fee...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1978
• Employees: 152
• Stock Exchange: Nasdaq
• Ticker Symbol: UTMD
• Website: https://www.utahmed.com

Financial Performance

In 2025, Utah Medical Products's revenue was $38.52 million, a decrease of -5.83% compared to the previous year's $40.90 million. Earnings were $11.29 million, a decrease of -18.65%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 16, 2026

Data Sources Report a data error